Search research articles
Contact Us
Filters
Showing results (61-70 of 98) with videos related to
Page
of 10
Sort By:
The Journal of Antimicrobial Chemotherapy
|
March 11, 2021
No difference in HIV-1 integrase inhibitor resistance between CSF and blood compartments
Basma Abdi, Mouna Chebbi, Marc Wirden, et al.
Antimicrobial Agents and Chemotherapy
|
January 25, 2003
Genotypic inhibitory quotient as predictor of virological response to ritonavir-amprenavir in human immunodeficiency virus type 1 protease inhibitor-experienced patients
Anne-Geneviève Marcelin, Claire Lamotte, Constance Delaugerre, et al.
The Journal of Infectious Diseases
|
August 20, 2021
Kinetics of Archived M184V Mutation in Treatment-Experienced Virally Suppressed HIV-Infected Patients
Romain Palich, Elisa Teyssou, Sophie Sayon, et al.
The Journal of Antimicrobial Chemotherapy
|
July 6, 2019
Antiretroviral drug reduction in highly experienced HIV-infected patients receiving a multidrug regimen: the ECOVIR study
Marc-Antoine Valantin, Lise Durand, Marc Wirden, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
July 28, 2020
Evolution of viral quasispecies during SARS-CoV-2 infection
Aude Jary, Valentin Leducq, Isabelle Malet, et al.
Antiviral Research
|
December 6, 2011
E17A mutation in HIV-1 Vpr confers resistance to didanosine in association with thymidine analog mutations
Slim Fourati, Isabelle Malet, Carolin A Guenzel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 29, 2021
Neutralization Heterogeneity of UK and South African Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants in BNT162b2-Vaccinated or Convalescent Coronavirus Disease 2019 (COVID-19) Healthcare Workers
Stéphane Marot, Isabelle Malet, Valentin Leducq, et al.
Plos One
|
August 1, 2012
Similar evolution of cellular HIV-1 DNA level in darunavir/ritonavir monotherapy versus triple therapy in MONOI-ANRS136 trial over 96 weeks
Sidonie Lambert-Niclot, Philippe Flandre, Marc-Antoine Valantin, et al.
Open Forum Infectious Diseases
|
May 25, 2019
INSTI-Based Triple Regimens in Treatment-Naïve HIV-Infected Patients Are Associated With HIV-RNA Viral Load Suppression at Ultralow Levels
Sidonie Lambert-Niclot, Anders Boyd, Djeneba Fofana, et al.
The Journal of Antimicrobial Chemotherapy
|
December 20, 2024
Changes in NNRTI use have not altered the ecology of NNRTI resistance over the last 10 years in people with HIV experiencing virological failure on antiretroviral drugs
Cathia Soulie, Rachid Agher, Antoine Fauchois, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 98) with videos related to
Sort By:
Page
of 10
The Journal of Antimicrobial Chemotherapy
|
March 11, 2021
No difference in HIV-1 integrase inhibitor resistance between CSF and blood compartments
Basma Abdi, Mouna Chebbi, Marc Wirden, et al.
Antimicrobial Agents and Chemotherapy
|
January 25, 2003
Genotypic inhibitory quotient as predictor of virological response to ritonavir-amprenavir in human immunodeficiency virus type 1 protease inhibitor-experienced patients
Anne-Geneviève Marcelin, Claire Lamotte, Constance Delaugerre, et al.
The Journal of Infectious Diseases
|
August 20, 2021
Kinetics of Archived M184V Mutation in Treatment-Experienced Virally Suppressed HIV-Infected Patients
Romain Palich, Elisa Teyssou, Sophie Sayon, et al.
The Journal of Antimicrobial Chemotherapy
|
July 6, 2019
Antiretroviral drug reduction in highly experienced HIV-infected patients receiving a multidrug regimen: the ECOVIR study
Marc-Antoine Valantin, Lise Durand, Marc Wirden, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
July 28, 2020
Evolution of viral quasispecies during SARS-CoV-2 infection
Aude Jary, Valentin Leducq, Isabelle Malet, et al.
Antiviral Research
|
December 6, 2011
E17A mutation in HIV-1 Vpr confers resistance to didanosine in association with thymidine analog mutations
Slim Fourati, Isabelle Malet, Carolin A Guenzel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 29, 2021
Neutralization Heterogeneity of UK and South African Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants in BNT162b2-Vaccinated or Convalescent Coronavirus Disease 2019 (COVID-19) Healthcare Workers
Stéphane Marot, Isabelle Malet, Valentin Leducq, et al.
Plos One
|
August 1, 2012
Similar evolution of cellular HIV-1 DNA level in darunavir/ritonavir monotherapy versus triple therapy in MONOI-ANRS136 trial over 96 weeks
Sidonie Lambert-Niclot, Philippe Flandre, Marc-Antoine Valantin, et al.
Open Forum Infectious Diseases
|
May 25, 2019
INSTI-Based Triple Regimens in Treatment-Naïve HIV-Infected Patients Are Associated With HIV-RNA Viral Load Suppression at Ultralow Levels
Sidonie Lambert-Niclot, Anders Boyd, Djeneba Fofana, et al.
The Journal of Antimicrobial Chemotherapy
|
December 20, 2024
Changes in NNRTI use have not altered the ecology of NNRTI resistance over the last 10 years in people with HIV experiencing virological failure on antiretroviral drugs
Cathia Soulie, Rachid Agher, Antoine Fauchois, et al.
Page
of 10